ku 1257 has been researched along with roxatidine acetate in 2 studies
| Studies (ku 1257) | Trials (ku 1257) | Recent Studies (post-2010) (ku 1257) | Studies (roxatidine acetate) | Trials (roxatidine acetate) | Recent Studies (post-2010) (roxatidine acetate) |
|---|---|---|---|---|---|
| 14 | 0 | 8 | 137 | 48 | 17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamada, K; Kobayashi, F; Sekiguchi, H; Taga, F; Uchida, H | 1 |
| Aijima, H; Hamada, K; Nishino, K; Sekiguchi, H; Taga, F; Uchida, H | 1 |
2 other study(ies) available for ku 1257 and roxatidine acetate
| Article | Year |
|---|---|
Pharmacological profiles of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy] propyl] urea.
Topics: Animals; Cerebral Cortex; Cimetidine; Dogs; Famotidine; Food; Gastric Acid; Guinea Pigs; Heart Atria; Heart Rate; Histamine H2 Antagonists; In Vitro Techniques; Kinetics; Male; Phenylurea Compounds; Piperidines; Pylorus; Rats; Rats, Wistar; Tetragastrin | 1993 |
Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
Topics: Acetates; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Duodenal Ulcer; Famotidine; Gastric Mucosa; Histamine H2 Antagonists; Intestinal Mucosa; Male; Phenylurea Compounds; Piperidines; Rats; Rats, Wistar; Stomach Ulcer | 1993 |